Patents by Inventor Jiangsong LOU

Jiangsong LOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
    Publication number: 20240101552
    Abstract: Provided is the carbonyl heterocyclic compound shown in formula (I) or a pharmaceutically acceptable salt thereof, capable of being used as a compound having a targeted lanthionine synthetase C-like protein 2 pathway and being used for the treatment of various conditions, including infectious diseases, autoimmune diseases, diabetes, and chronic inflammatory diseases.
    Type: Application
    Filed: September 18, 2021
    Publication date: March 28, 2024
    Inventors: Chaoxin ZHANG, Guangxin XIA, Zhijun XIANG, Ying KE, Jiangsong LOU, Menghao ZHAO, Lijun HAO
  • Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use Therefor
    Publication number: 20220324868
    Abstract: Disclosed in the present invention are a pyrazolone-fused pyrimidine compound, and a preparation method and a use therefor. Provided in the present invention is a pyrazolone-fused pyrimidine compound as in formula (I), said compound having better inhibitory activity towards WEE1 kinase.
    Type: Application
    Filed: August 28, 2020
    Publication date: October 13, 2022
    Inventors: Qian WANG, Guoyong HUO, Guangxin XIA, Jiangsong LOU, Sijie SHU, Hui GE, Lin ZHANG, Chen SHI, Zhihui ZHANG, Yu MAO, Bingbin ZHANG, Jianxin YU, Yanjun LIU, Ying KE, Chi ZHANG
  • Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications Thereof
    Publication number: 20220259210
    Abstract: Disclosed are a pyrazolone-fused pyrimidine compound, a preparation method for same and applications thereof. Provided in the present invention is the pyrazolone-fused pyrimidine compound as represented by formula (II). The compound has improved inhibitory activity with respect to WEE1 kinase.
    Type: Application
    Filed: June 28, 2020
    Publication date: August 18, 2022
    Inventors: Qian WANG, Sijie SHU, Guangxin XIA, Hui GE, Bingbin ZHANG, Guoyong HUO, Lin ZHANG, Chen SHI, Jiangsong LOU, Chi ZHANG, Zhihui ZHANG, Yu MAO, Jianxin YU, Ying KE, Yanjun LIU